4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001665124-26-000008
President and Head of R&D sold 116,050 shares at an average $4.72 ($547,469)
From the SEC's structured data for this filing
Trades in this filing
Nagendran Sukumar · President and Head of R&D
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-23 | Sale : show line 1 in the form | −89,132 | $4.75 | $423,377 | 1,344,307 | D |
| 2026-01-26 | Sale : show line 2 in the form | −26,918 | $4.61 | $124,092 | 1,317,389 | D |
| Open-market sales · 116,050 sh · avg $4.72 · $547,469 | ||||||
Loading xslF345X05/form4-01272026_040105.xml…